Nasal Steam Therapy for Post-extubation Respiratory Events

Launched by ILSAN CHA HOSPITAL · Feb 17, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called nasal steam therapy to see if it helps improve breathing problems that some patients experience after being on a breathing machine (intubation) during thyroid surgery. The study will compare the effects of nasal steam therapy to standard care for patients aged 19 to 69 who have had their thyroid gland removed due to a tumor. Researchers will measure how well these treatments work using a specific survey about upper respiratory symptoms.

To participate, you need to be between 19 and 69 years old, have had thyroid surgery with intubation, and developed breathing issues afterward. You also need to be in good overall health (ASA status I or II). However, if you have chronic cough, certain respiratory infections, or are planning other major treatments, you may not be eligible. If you join the trial, you can expect to receive either the nasal steam therapy or the usual treatment and complete surveys about your symptoms during the study. This trial is currently recruiting participants, so if you're interested, please talk to your healthcare provider for more information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age of 19 to 69 years
• • Those who underwent surgical removal of the thyroid gland under endotracheal intubation due to a thyroid tumor
• • American Society of Anesthesiologists (ASA) status I or II
• • Those who developed upper respiratory symptoms after surgery ⑤ Voluntarily decided to participate in this clinical trial and signed the informed consent form
• Exclusion criteria:
• • Those diagnosed with symptomatic gastroesophageal reflux disease
• • Chronic cough lasting for more than 3 months prior to surgery, including bronchial asthma and chronic obstructive pulmonary disease (COPD)
• • Those who developed other respiratory infections within the past month ④ Those who are taking or are required to take other medications that may interfere with the interpretation of the treatment effect or results
• • Those who are scheduled to undergo additional major treatments such as reoperation, chemotherapy, and radiotherapy during the clinical trial period ⑥ Pregnant women, breastfeeding women, and those who plan to become pregnant during the study period ⑦ Others who are expected to have difficulty complying with the treatment, visits, and questionnaires stipulated in this protocol at the discretion of the medical staff